Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

DESTINY-PANTUMOUR04 — Stella

Home/Adenocarcinoma (NOS)/DESTINY-PANTUMOUR04

View on ClinicalTrials.gov

Recruiting

Back to Adenocarcinoma (NOS) trials

DESTINY-PANTUMOUR04

Trial locations(15 sites)

United States

Research Site, Birmingham, Alabama

Research Site, Casa Grande, Arizona

Research Site, San Diego, California

Research Site, Aurora, Colorado

Research Site, Coral Springs, Florida

Research Site, Fort Myers, Florida

Research Site, Palm Harbor, Florida

Research Site, O'Fallon, Illinois

Research Site, Durham, North Carolina

Research Site, Wilson, North Carolina

Research Site, Canton, Ohio

Research Site, Maumee, Ohio

Research Site, Philadelphia, Pennsylvania

Research Site, Chattanooga, Tennessee

Research Site, Dallas, Texas

Key details

Sponsor

AstraZeneca

Enrollment target

~100 participants

Started

September 2025

Primary completion

March 2028

Age range

18 Years – 130 Years

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.